Investors Buy Monsanto (MON) on Weakness

Traders bought shares of Monsanto (NYSE:MON) on weakness during trading on Friday. $138.93 million flowed into the stock on the tick-up and $103.76 million flowed out of the stock on the tick-down, for a money net flow of $35.17 million into the stock. Of all stocks tracked, Monsanto had the 14th highest net in-flow for the day. Monsanto traded down ($0.44) for the day and closed at $118.64

Several equities research analysts have recently issued reports on the company. Royal Bank of Canada reiterated a “hold” rating and set a $128.00 price target on shares of Monsanto in a report on Wednesday, November 15th. Deutsche Bank restated a “buy” rating on shares of Monsanto in a report on Tuesday, January 16th. Wells Fargo & Co restated a “market perform” rating and issued a $128.00 target price (up from $118.00) on shares of Monsanto in a report on Wednesday, January 17th. Finally, Zacks Investment Research lowered Monsanto from a “buy” rating to a “hold” rating in a report on Monday, December 11th. Eleven investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of $127.30.

The company has a quick ratio of 0.79, a current ratio of 1.28 and a debt-to-equity ratio of 1.05. The company has a market cap of $52,296.63, a price-to-earnings ratio of 20.71, a price-to-earnings-growth ratio of 1.70 and a beta of 1.01.

Monsanto (NYSE:MON) last issued its quarterly earnings results on Thursday, January 4th. The basic materials company reported $0.41 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.42 by ($0.01). The business had revenue of $2.66 billion during the quarter, compared to the consensus estimate of $2.77 billion. Monsanto had a return on equity of 40.13% and a net margin of 16.38%. The business’s quarterly revenue was up .3% on a year-over-year basis. During the same period in the prior year, the firm earned $0.21 earnings per share. equities research analysts anticipate that Monsanto will post 5.76 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 27th. Shareholders of record on Friday, April 6th will be given a $0.54 dividend. This represents a $2.16 annualized dividend and a yield of 1.82%. The ex-dividend date of this dividend is Thursday, April 5th. Monsanto’s dividend payout ratio is currently 39.85%.

In other Monsanto news, EVP Steven Mizell sold 8,100 shares of Monsanto stock in a transaction that occurred on Tuesday, January 9th. The stock was sold at an average price of $119.35, for a total value of $966,735.00. Following the transaction, the executive vice president now directly owns 56,743 shares of the company’s stock, valued at approximately $6,772,277.05. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 0.79% of the company’s stock.

Hedge funds and other institutional investors have recently modified their holdings of the business. Gradient Investments LLC bought a new position in Monsanto in the 4th quarter worth approximately $108,000. Americafirst Capital Management LLC bought a new position in Monsanto in the 3rd quarter worth approximately $148,000. S&CO Inc. bought a new position in Monsanto in the 3rd quarter worth approximately $216,000. McKinley Carter Wealth Services Inc. bought a new position in Monsanto in the 4th quarter worth approximately $218,000. Finally, Corundum Group Inc. bought a new position in Monsanto in the 3rd quarter worth approximately $228,000. 75.62% of the stock is currently owned by institutional investors.

TRADEMARK VIOLATION NOTICE: “Investors Buy Monsanto (MON) on Weakness” was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this article on another site, it was illegally stolen and republished in violation of international copyright & trademark law. The correct version of this article can be accessed at https://www.dispatchtribunal.com/2018/02/11/investors-buy-monsanto-mon-on-weakness.html.

Monsanto Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply